GL Greene

414 total citations
7 papers, 360 citations indexed

About

GL Greene is a scholar working on Genetics, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, GL Greene has authored 7 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 4 papers in Oncology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in GL Greene's work include Estrogen and related hormone effects (4 papers), Advanced Breast Cancer Therapies (2 papers) and Bioactive Compounds and Antitumor Agents (1 paper). GL Greene is often cited by papers focused on Estrogen and related hormone effects (4 papers), Advanced Breast Cancer Therapies (2 papers) and Bioactive Compounds and Antitumor Agents (1 paper). GL Greene collaborates with scholars based in United States. GL Greene's co-authors include David J. McConkey, Curtis A. Pettaway, Zafar Nawaz, McGuire Wl, Suzanne A.W. Fuqua, Barry S. Komm, Sarat Chandarlapaty, José Baselga, Pedram Razavi and Marianne E. Greene and has published in prestigious journals such as Cancer Research, PLoS Computational Biology and PubMed.

In The Last Decade

GL Greene

5 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
GL Greene United States	3	219	200	138	70	48	7	360
Antonietta de Falco Italy	7	277 1.3×	250 1.3×	142 1.0×	55 0.8×	107 2.2×	8	490
Massimo Cancemi Italy	8	240 1.1×	189 0.9×	165 1.2×	81 1.2×	45 0.9×	9	411
P A O'Neill United Kingdom	7	227 1.0×	197 1.0×	203 1.5×	98 1.4×	25 0.5×	7	425
Chun‐Fui Lai United Kingdom	10	228 1.0×	132 0.7×	151 1.1×	110 1.6×	41 0.9×	13	421
Annabell S. Oh United States	12	395 1.8×	325 1.6×	277 2.0×	118 1.7×	55 1.1×	13	615
Alicia Parkes United Kingdom	5	332 1.5×	464 2.3×	312 2.3×	145 2.1×	39 0.8×	10	641
Romina P. Carnevale Argentina	7	215 1.0×	142 0.7×	218 1.6×	89 1.3×	25 0.5×	9	454
Katia Bouchekioua‐Bouzaghou France	8	297 1.4×	123 0.6×	118 0.9×	34 0.5×	49 1.0×	9	415
Najeeba Ali United States	5	188 0.9×	141 0.7×	177 1.3×	81 1.2×	79 1.6×	6	363
Nicole Carlson United States	6	186 0.8×	144 0.7×	175 1.3×	83 1.2×	45 0.9×	6	352

Countries citing papers authored by GL Greene

Since Specialization

Citations

This map shows the geographic impact of GL Greene's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by GL Greene with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites GL Greene more than expected).

Fields of papers citing papers by GL Greene

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by GL Greene. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by GL Greene. The network helps show where GL Greene may publish in the future.

Co-authorship network of co-authors of GL Greene

This figure shows the co-authorship network connecting the top 25 collaborators of GL Greene. A scholar is included among the top collaborators of GL Greene based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with GL Greene. GL Greene is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Greene, GL, et al.. (2025). A Boolean network model of hypoxia, mechanosensing and TGF-β signaling captures the role of phenotypic plasticity and mutations in tumor metastasis. PLoS Computational Biology. 21(4). e1012735–e1012735.

2.

Toy, Weiyi, Pedram Razavi, Michael F. Berger, et al.. (2019). Abstract P5-04-11: Non-canonical, clinical ESR1 mutations promote resistance to antiestrogen therapies. Cancer Research. 79(4_Supplement). P5–4.

3.

Greene, GL, et al.. (2019). Abstract OT1-01-02: An open-label, randomized, multi-center phase 2 study evaluating the activity of lasofoxifene relative to fulvestrant for the treatment of postmenopausal women with locally advanced or metastatic ER+/HER2 - breast cancer (MBC) with an ESR1 mutation. Cancer Research. 79(4_Supplement). OT1–1. 2 indexed citations

4.

Laine, Minna, et al.. (2019). Abstract PD7-09: Lasofoxifene decreases breast cancer lung and liver metastasis in a mammary intraductal (MIND) xenograft model of mutant ERα+ breast cancer. Cancer Research. 79(4_Supplement). PD7–9. 1 indexed citations

5.

Greene, GL, et al.. (2017). Abstract P3-04-19: Inhibition of ER-positive breast cancer progression with duavee, a new form of hormone replacement therapy. Cancer Research. 77(4_Supplement). P3–4. 1 indexed citations

6.

McConkey, David J., GL Greene, & Curtis A. Pettaway. (1996). Apoptosis resistance increases with metastatic potential in cells of the human LNCaP prostate carcinoma line.. PubMed. 56(24). 5594–9. 134 indexed citations

7.

Fuqua, Suzanne A.W., et al.. (1992). Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors.. Cancer Research. 52(2). 483–6. 222 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact